These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 28273561)

  • 21. Effects of new 4-aryl-1,4-dihydropyridines and 4-arylpyridines on drug efflux mediated by multidrug resistance-associated protein 1.
    Zhou XF; Coburn RA; Morris ME
    J Pharm Sci; 2005 Oct; 94(10):2256-65. PubMed ID: 16136554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diaminothiazoles evade multidrug resistance in cancer cells and xenograft tumour models and develop transient specific resistance: understanding the basis of broad-spectrum versus specific resistance.
    Vasudevan S; Thomas SA; Sivakumar KC; Komalam RJ; Sreerekha KV; Rajasekharan KN; Sengupta S
    Carcinogenesis; 2015 Aug; 36(8):883-93. PubMed ID: 26014355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells.
    Shekari F; Sadeghpour H; Javidnia K; Saso L; Nazari F; Firuzi O; Miri R
    Eur J Pharmacol; 2015 Jan; 746():233-44. PubMed ID: 25445037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidrug resistance protein 1 (MRP1, ABCC1) mediates resistance to mitoxantrone via glutathione-dependent drug efflux.
    Morrow CS; Peklak-Scott C; Bishwokarma B; Kute TE; Smitherman PK; Townsend AJ
    Mol Pharmacol; 2006 Apr; 69(4):1499-505. PubMed ID: 16434618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer multidrug resistance mediated by MRP1: recent advances in the discovery of reversal agents.
    Boumendjel A; Baubichon-Cortay H; Trompier D; Perrotton T; Di Pietro A
    Med Res Rev; 2005 Jul; 25(4):453-72. PubMed ID: 15834856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-acetylcysteine enhances multidrug resistance-associated protein 1 mediated doxorubicin resistance.
    Akan I; Akan S; Akca H; Savas B; Ozben T
    Eur J Clin Invest; 2004 Oct; 34(10):683-9. PubMed ID: 15473893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells.
    Yang CH; Kuo ML; Chen JC; Chen YC
    Br J Cancer; 1999 Nov; 81(5):796-9. PubMed ID: 10555748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins.
    Iida T; Kijima H; Urata Y; Goto S; Ihara Y; Oka M; Kohno S; Scanlon KJ; Kondo T
    Cancer Gene Ther; 2001 Oct; 8(10):803-14. PubMed ID: 11687904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylenedioxy flavonoids: assessment of cytotoxic and anti-cancer potential in human leukemia cells.
    Orlikova B; Menezes JC; Ji S; Kamat SP; Cavaleiro JA; Diederich M
    Eur J Med Chem; 2014 Sep; 84():173-80. PubMed ID: 25016375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
    Wesołowska O; Wiśniewski J; Sroda-Pomianek K; Bielawska-Pohl A; Paprocka M; Duś D; Duarte N; Ferreira MJ; Michalak K
    J Nat Prod; 2012 Nov; 75(11):1896-902. PubMed ID: 23137376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total synthesis and bioactivity of unique flavone desmosdumotin B and its analogs.
    Nakagawa-Goto K; Bastow KF; Wu JH; Tokuda H; Lee KH
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3016-9. PubMed ID: 15913998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of Novel Flavonoid Dimers To Reverse Multidrug Resistance Protein 1 (MRP1, ABCC1) Mediated Drug Resistance in Cancers Using a High Throughput Platform with "Click Chemistry".
    Wong ILK; Zhu X; Chan KF; Law MC; Lo AMY; Hu X; Chow LMC; Chan TH
    J Med Chem; 2018 Nov; 61(22):9931-9951. PubMed ID: 30351934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidrug-resistant cancer cell susceptibility to cytotoxic quassinoids, and cancer chemopreventive effects of quassinoids and canthin alkaloids.
    Murakami C; Fukamiya N; Tamura S; Okano M; Bastow KF; Tokuda H; Mukainaka T; Nishino H; Lee KH
    Bioorg Med Chem; 2004 Sep; 12(18):4963-8. PubMed ID: 15336275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cells.
    Ascione A; Cianfriglia M; Dupuis ML; Mallano A; Sau A; Pellizzari Tregno F; Pezzola S; Caccuri AM
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):419-24. PubMed ID: 19288261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversion of multidrug resistance in a chemoresistant human breast cancer cell line by β-elemene.
    Xu HB; Li L; Fu J; Mao XP; Xu LZ
    Pharmacology; 2012; 89(5-6):303-12. PubMed ID: 22573000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of a series of flavone derivatives as potential radioligands for imaging the multidrug resistance-associated protein 1 (ABCC1/MRP1).
    Mavel S; Dikic B; Palakas S; Emond P; Greguric I; de Gracia AG; Mattner F; Garrigos M; Guilloteau D; Katsifis A
    Bioorg Med Chem; 2006 Mar; 14(5):1599-607. PubMed ID: 16263302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenylsulfonylfuroxans as modulators of multidrug-resistance-associated protein-1 and P-glycoprotein.
    Fruttero R; Crosetti M; Chegaev K; Guglielmo S; Gasco A; Berardi F; Niso M; Perrone R; Panaro MA; Colabufo NA
    J Med Chem; 2010 Aug; 53(15):5467-75. PubMed ID: 20684594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy.
    Angelini A; Di Ilio C; Castellani ML; Conti P; Cuccurullo F
    J Biol Regul Homeost Agents; 2010; 24(2):197-205. PubMed ID: 20487633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Ganguly A; Chakraborty P; Banerjee K; Chatterjee S; Basu S; Sarkar A; Chatterjee M; Choudhuri SK
    Biometals; 2012 Feb; 25(1):149-63. PubMed ID: 21915630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. β-Elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporter.
    Guo HQ; Zhang GN; Wang YJ; Zhang YK; Sodani K; Talele TT; Ashby CR; Chen ZS
    Oncol Rep; 2014 Feb; 31(2):858-66. PubMed ID: 24284783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.